Therapeutic potential of the annexin A family in atherosclerosis
Abstract Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality and morbidity worldwide despite advancements in therapeutic options for the management of atherosclerosis (AS). Treatments that lower low‐density lipoprotein (LDL) cholesterol levels, such as statins or proprot...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | englanti |
| Julkaistu: |
Wiley
2025-06-01
|
| Sarja: | Clinical and Translational Discovery |
| Aiheet: | |
| Linkit: | https://doi.org/10.1002/ctd2.70064 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|